Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005811 | lipid droplet | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: E9APD9
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009056 | catabolic process | 2 | 12 |
GO:0016042 | lipid catabolic process | 4 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:1901575 | organic substance catabolic process | 3 | 12 |
GO:0006638 | neutral lipid metabolic process | 4 | 1 |
GO:0006639 | acylglycerol metabolic process | 5 | 1 |
GO:0006641 | triglyceride metabolic process | 6 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0019433 | triglyceride catabolic process | 7 | 1 |
GO:0042592 | homeostatic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044242 | cellular lipid catabolic process | 4 | 1 |
GO:0044248 | cellular catabolic process | 3 | 1 |
GO:0044255 | cellular lipid metabolic process | 3 | 1 |
GO:0046461 | neutral lipid catabolic process | 5 | 1 |
GO:0046464 | acylglycerol catabolic process | 6 | 1 |
GO:0046486 | glycerolipid metabolic process | 4 | 1 |
GO:0046503 | glycerolipid catabolic process | 5 | 1 |
GO:0048878 | chemical homeostasis | 4 | 1 |
GO:0055088 | lipid homeostasis | 5 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0065008 | regulation of biological quality | 2 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0016787 | hydrolase activity | 2 | 12 |
GO:0004806 | triglyceride lipase activity | 5 | 1 |
GO:0016298 | lipase activity | 4 | 1 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 1 |
GO:0052689 | carboxylic ester hydrolase activity | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 105 | 107 | PF00675 | 0.507 |
CLV_NRD_NRD_1 | 259 | 261 | PF00675 | 0.544 |
CLV_NRD_NRD_1 | 276 | 278 | PF00675 | 0.578 |
CLV_PCSK_KEX2_1 | 105 | 107 | PF00082 | 0.551 |
CLV_PCSK_KEX2_1 | 276 | 278 | PF00082 | 0.610 |
CLV_PCSK_SKI1_1 | 106 | 110 | PF00082 | 0.575 |
CLV_PCSK_SKI1_1 | 129 | 133 | PF00082 | 0.522 |
CLV_PCSK_SKI1_1 | 245 | 249 | PF00082 | 0.641 |
CLV_PCSK_SKI1_1 | 29 | 33 | PF00082 | 0.328 |
CLV_PCSK_SKI1_1 | 56 | 60 | PF00082 | 0.336 |
DEG_APCC_KENBOX_2 | 147 | 151 | PF00400 | 0.450 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 299 | 308 | PF00134 | 0.535 |
DOC_MAPK_FxFP_2 | 241 | 244 | PF00069 | 0.458 |
DOC_MAPK_gen_1 | 127 | 136 | PF00069 | 0.428 |
DOC_MAPK_gen_1 | 14 | 23 | PF00069 | 0.454 |
DOC_MAPK_MEF2A_6 | 127 | 136 | PF00069 | 0.347 |
DOC_MAPK_NFAT4_5 | 127 | 135 | PF00069 | 0.425 |
DOC_PP4_FxxP_1 | 241 | 244 | PF00568 | 0.458 |
DOC_SPAK_OSR1_1 | 97 | 101 | PF12202 | 0.364 |
DOC_USP7_UBL2_3 | 12 | 16 | PF12436 | 0.458 |
DOC_USP7_UBL2_3 | 25 | 29 | PF12436 | 0.408 |
DOC_WW_Pin1_4 | 14 | 19 | PF00397 | 0.445 |
DOC_WW_Pin1_4 | 291 | 296 | PF00397 | 0.452 |
LIG_14-3-3_CanoR_1 | 129 | 135 | PF00244 | 0.226 |
LIG_14-3-3_CanoR_1 | 97 | 107 | PF00244 | 0.356 |
LIG_BRCT_BRCA1_1 | 295 | 299 | PF00533 | 0.449 |
LIG_BRCT_BRCA1_1 | 314 | 318 | PF00533 | 0.444 |
LIG_deltaCOP1_diTrp_1 | 159 | 163 | PF00928 | 0.417 |
LIG_deltaCOP1_diTrp_1 | 279 | 288 | PF00928 | 0.436 |
LIG_FHA_1 | 15 | 21 | PF00498 | 0.431 |
LIG_FHA_1 | 40 | 46 | PF00498 | 0.328 |
LIG_FHA_2 | 159 | 165 | PF00498 | 0.426 |
LIG_FHA_2 | 99 | 105 | PF00498 | 0.361 |
LIG_FXI_DFP_1 | 160 | 164 | PF00024 | 0.612 |
LIG_LIR_Apic_2 | 239 | 244 | PF02991 | 0.468 |
LIG_LIR_Gen_1 | 159 | 167 | PF02991 | 0.395 |
LIG_LIR_Nem_3 | 159 | 163 | PF02991 | 0.404 |
LIG_LIR_Nem_3 | 298 | 304 | PF02991 | 0.440 |
LIG_PDZ_Class_2 | 315 | 320 | PF00595 | 0.459 |
LIG_PTB_Apo_2 | 235 | 242 | PF02174 | 0.407 |
LIG_PTB_Apo_2 | 92 | 99 | PF02174 | 0.389 |
LIG_SH2_SRC | 210 | 213 | PF00017 | 0.346 |
LIG_SH2_STAT3 | 143 | 146 | PF00017 | 0.425 |
LIG_SH2_STAT3 | 50 | 53 | PF00017 | 0.402 |
LIG_SH2_STAT5 | 152 | 155 | PF00017 | 0.477 |
LIG_SH2_STAT5 | 205 | 208 | PF00017 | 0.357 |
LIG_SH2_STAT5 | 210 | 213 | PF00017 | 0.341 |
LIG_SH2_STAT5 | 235 | 238 | PF00017 | 0.440 |
LIG_SH2_STAT5 | 287 | 290 | PF00017 | 0.533 |
LIG_SH2_STAT5 | 50 | 53 | PF00017 | 0.402 |
LIG_SH3_3 | 20 | 26 | PF00018 | 0.449 |
LIG_SH3_4 | 25 | 32 | PF00018 | 0.388 |
LIG_TRAF2_1 | 101 | 104 | PF00917 | 0.353 |
LIG_WRC_WIRS_1 | 31 | 36 | PF05994 | 0.328 |
MOD_CK1_1 | 197 | 203 | PF00069 | 0.382 |
MOD_CK2_1 | 98 | 104 | PF00069 | 0.347 |
MOD_DYRK1A_RPxSP_1 | 14 | 18 | PF00069 | 0.459 |
MOD_GlcNHglycan | 68 | 71 | PF01048 | 0.413 |
MOD_GSK3_1 | 130 | 137 | PF00069 | 0.335 |
MOD_GSK3_1 | 171 | 178 | PF00069 | 0.362 |
MOD_N-GLC_1 | 312 | 317 | PF02516 | 0.665 |
MOD_NEK2_1 | 130 | 135 | PF00069 | 0.327 |
MOD_NEK2_1 | 191 | 196 | PF00069 | 0.444 |
MOD_NEK2_1 | 39 | 44 | PF00069 | 0.317 |
MOD_NEK2_1 | 59 | 64 | PF00069 | 0.344 |
MOD_PIKK_1 | 142 | 148 | PF00454 | 0.494 |
MOD_PIKK_1 | 175 | 181 | PF00454 | 0.453 |
MOD_PKA_2 | 191 | 197 | PF00069 | 0.379 |
MOD_Plk_4 | 191 | 197 | PF00069 | 0.387 |
MOD_Plk_4 | 59 | 65 | PF00069 | 0.344 |
MOD_ProDKin_1 | 14 | 20 | PF00069 | 0.438 |
MOD_ProDKin_1 | 291 | 297 | PF00069 | 0.451 |
TRG_DiLeu_BaEn_1 | 54 | 59 | PF01217 | 0.593 |
TRG_ER_diArg_1 | 105 | 107 | PF00400 | 0.310 |
TRG_ER_diArg_1 | 276 | 278 | PF00400 | 0.392 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P891 | Leptomonas seymouri | 90% | 100% |
A0A0S4ISG1 | Bodo saltans | 68% | 100% |
A0A1X0NN13 | Trypanosomatidae | 78% | 100% |
A0A3S7WSN3 | Leishmania donovani | 97% | 100% |
A0A422MYV8 | Trypanosoma rangeli | 79% | 100% |
A4H7A1 | Leishmania braziliensis | 93% | 100% |
A4HVP3 | Leishmania infantum | 97% | 100% |
D0A6N7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 77% | 100% |
Q4QG39 | Leishmania major | 95% | 100% |
V5BB21 | Trypanosoma cruzi | 79% | 100% |